Insulin Pump



Indications and Reactions:

Role Indications Reactions
Primary
Diabetes Mellitus 75.0%
Type 1 Diabetes Mellitus 16.7%
Type 1 Diabetes Mellitus 8.3%
Treatment Noncompliance 16.7%
Unresponsive To Stimuli 16.7%
Blood Glucose Decreased 8.3%
Hyperglycaemia 8.3%
Hypoglycaemia 8.3%
Loss Of Consciousness 8.3%
Metabolic Acidosis 8.3%
No Therapeutic Response 8.3%
Thoracic Vertebral Fracture 8.3%
Tremor 8.3%
Secondary
Hepatitis C 21.4%
Type 1 Diabetes Mellitus 17.9%
Type 2 Diabetes Mellitus 17.9%
Anaemia 10.7%
Hypothyroidism 10.7%
Osteoporosis 10.7%
Thyroid Disorder 10.7%
Ketoacidosis 11.8%
Somnolence 11.8%
Stevens-johnson Syndrome 11.8%
Weight Decreased 11.8%
Blood Glucose Increased 5.9%
Cellulitis 5.9%
Headache 5.9%
Hyperglycaemia 5.9%
Hypoglycaemia 5.9%
Hypoglycaemic Seizure 5.9%
Medical Device Complication 5.9%
Pharmaceutical Product Complaint 5.9%
Stomach Discomfort 5.9%
Concomitant
Product Used For Unknown Indication 29.8%
Drug Use For Unknown Indication 12.3%
Diabetes Mellitus 9.4%
Hypertension 6.1%
Rheumatoid Arthritis 5.5%
Multiple Sclerosis 4.4%
Type 1 Diabetes Mellitus 4.1%
Depression 3.5%
Gastrooesophageal Reflux Disease 3.5%
Pain 3.3%
Blood Cholesterol Increased 2.9%
Vitamin Supplementation 2.3%
Diabetes Mellitus Insulin-dependent 1.9%
Hypothyroidism 1.9%
Renal Transplant 1.7%
Atrial Fibrillation 1.6%
Asthma 1.5%
Blood Triglycerides Increased 1.5%
High Density Lipoprotein Decreased 1.5%
Prophylaxis 1.5%
Blood Glucose Increased 12.6%
Urticaria 9.2%
Injection Site Pain 8.0%
Vomiting 6.9%
Weight Decreased 6.9%
Rash 5.7%
Weight Increased 5.7%
Joint Swelling 4.6%
Paraesthesia 4.6%
Pruritus 4.6%
Tooth Abscess 4.6%
Diarrhoea 3.4%
Hepatic Enzyme Increased 3.4%
Hypoglycaemia 3.4%
Malaise 3.4%
Wheezing 3.4%
Blood Pressure Increased 2.3%
Cough 2.3%
Electrocardiogram Qt Prolonged 2.3%
Fatigue 2.3%